SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001103021-22-000072
Filing Date
2022-03-22
Accepted
2022-03-22 17:16:38
Documents
1
Period of Report
2022-03-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_164798378306510.html 4  
1 FORM 4 wf-form4_164798378306510.xml 4 15662
  Complete submission text file 0001103021-22-000072.txt   17195
Mailing Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612
Business Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Issuer) CIK: 0001103021 (see all company filings)

IRS No.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address BIODELIVERY SCIENCES INTERNATIONAL, INC. 4131 PARKLAKE AVE SUITE 225 RALEIGH NC 27612
Business Address
Smith Thomas B (Reporting) CIK: 0001748462 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31361 | Film No.: 22760692